Evidence map›Paper›PMID 33445846›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2020

[Epidemiological analysis of pathogens causing bloodstream infections in department of hematology in Guangdong Province].

C Y Zhuo, Y Y Guo, N J Liu, B M Liu, S N Xiao, Y Zhang, X C Guo, D N Li, S Y Tan, N H He and 3 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Guideline
  2. Efficacy and safety of contezolid in the treatment of Gram-positive bacterial infections in patients with hematological malignancies: a retrospective study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  3. Investigation into Antibiotic Resistance Profiles ofInfection and drug resistance · 2025
    Article
  4. Article
  5. Extended-Spectrum β-Lactamase-ProducingRisk management and healthcare policy · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

C Y ZhuoThe First Affiliated Hospital of Guangzhou Medical, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, Guangzhou 510030, China.
Y Y GuoThe First Affiliated Hospital of Guangzhou Medical, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, Guangzhou 510030, China.
N J LiuThe First Affiliated Hospital of Guangzhou Medical, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, Guangzhou 510030, China.
B M LiuThe First Affiliated Hospital of Guangzhou Medical, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, Guangzhou 510030, China.
S N XiaoThe First Affiliated Hospital of Guangzhou Medical, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, Guangzhou 510030, China.
Y ZhangThe First Affiliated Hospital of Guangzhou Medical, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, Guangzhou 510030, China.
X C GuoThe First Affiliated Hospital of Guangzhou Medical, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, Guangzhou 510030, China.
D N LiThe First Affiliated Hospital of Guangzhou Medical, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, Guangzhou 510030, China.
S Y TanThe First Affiliated Hospital of Guangzhou Medical, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, Guangzhou 510030, China.
N H HeThe First Affiliated Hospital of Guangzhou Medical, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, Guangzhou 510030, China.
Y MaiThe First Affiliated Hospital of Guangzhou Medical, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, Guangzhou 510030, China.
J GuanThe First Affiliated Hospital of Guangzhou Medical, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, Guangzhou 510030, China.
C ZhuoThe First Affiliated Hospital of Guangzhou Medical, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, Guangzhou 510030, China.
First Affiliated Hospital of Guangzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Methicillin-Resistant Staphylococcus aureusAnti-Bacterial AgentsBacteremiaChinaDrug Resistance, BacterialEscherichia coliGram-Negative BacteriaHematologyHumansMicrobial Sensitivity TestsSepsisAnti-Bacterial AgentsBacterial resistance surveillanceBloodstream infectionStreptococcus viridans

Identifiers

PMID33445846
PMCPMC7840548
OpenAlexW3122524237

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.